Science News
DC Council signs life saving initiative into law
DC joins 37 states in passing Breast Density Screening and Notification Act to address little known risk factor for breast...
Gilteritinib improved survival for patients with acute myeloid leukemia
ATLANTA -- Treatment with the FLT3-targeted therapeutic gilteritinib (Xospata) improved survival for patients with relapsed or refractory acute myeloid leukemia...
Cancer preventive vaccine showed promising results in preclinical model of Lynch syndrome
ATLANTA -- Vaccination with as few as four tumor antigens generated antigen-specific responses, reduced intestinal tumors, and improved survival in...
Umbralisib shows early promise for patients with marginal zone lymphoma
ATLANTA -- The investigational therapeutic umbralisib, which targets the molecule PI3K-delta, was well tolerated and highly active in patients with...
Data from two KEYNOTE trials show pembrolizumab benefited patients with advanced SCLC
ATLANTA -- The anti-PD-1 monoclonal antibody pembrolizumab (Keytruda) showed promising antitumor activity with durable responses in patients with pretreated, advanced...
Targeted drug for leukemia tested at Penn Medicine helps patients live longer
Data presented at AACR Annual Meeting on recently approved drug that targets common mutation in AML ATLANTA - An inhibitor...
Single agent umbralisib effective for relapsed slow-growing lymphoma
MD Anderson Phase II trial shows drug well tolerated with high response rates for marginal zone lymphomaCredit: MD Anderson Cancer...
New evidence on the association of shortened sleep time and obstructive sleep apnea with sleepiness and cardiometabolic risk factors
Obstructive sleep apnea and short sleep duration have distinct clinical impacts; clinicians should avoid a 'one-size-fits-all' approach through proper diagnosis...
Compression-only CPR increases survival of out-of-hospital cardiac arrest
Circulation Journal Report DALLAS, April 1, 2019 -- A Swedish review of out-of-hospital cardiac arrest data shows rates of bystander...
Biopsy alternative: ‘Wearable’ device captures cancer cells from blood
Credit: Tae Hyun Kim ANN ARBOR, Michigan -- A prototype wearable device, tested in animal models, can continuously collect live...
Growth in telehealth from 2016 to 2017 outpaces other venues of care
FAIR Health market indices and trending reports once again bring valuable visibility into patient migratory patterns and healthcare costs NEW...
Enhanced recovery after spine surgery: 15 new articles in the April Neurosurgical Focus
Credit: © 2019 AANS CHARLOTTESVILLE, VA (APRIL 1, 2019). The April issue of Neurosurgical Focus (thejns.org/toc/foc/46/4) contains 15 new articles...
Just an hour of weekly walking staves off disability
All brisk walking, even short walks, help prevent disability in older adults with osteoarthritis CHICAGO --- Just one hour a...
New evidence about why clear margins in breast cancer surgery are such good news
Credit: Phil Jones, Senior Photographer, Augusta University AUGUSTA, Ga. (April 1, 2019) - When a breast cancer tumor is removed...
New glioblastoma vaccine shows promising results in phase Ib clinical trial
A brain-cancer vaccine more than 20 years in the making suspends cancer growth in patients enrolled in early-stage trial. (PHILADELPHIA)...
CD40 combination therapy can shrink pancreatic tumors
Study results to be presented during a plenary session at AACR Annual Meeting ATLANTA - A new combination of immunotherapy...
Excess body weight before 50 is associated with higher risk of dying from pancreatic cancer
ATLANTA --Excess weight before age 50 may be more strongly associated with pancreatic cancer mortality risk than excess weight at...
Pancreatic Cancer Collective funds two AI teams to identify high-risk populations
Computational tools seek to identify pancreatic cancer earlier, provide more opportunities for timely, effective treatmentsCredit: Pancreatic Cancer Collective (ATLANTA -...
Immunotherapy combination effective for patients with rare neuroendocrine cancer
Credit: Hope Foundation for Cancer Research A combination of two common immunotherapy drugs shrinks rare, aggressive neuroendocrine tumors, according to...
Adding savolitinib to osimertinib beneficial for certain pretreated lung cancer patients
ATLANTA -- Adding the investigational MET inhibitor savolitinib to the EGFR inhibitor osimertinib (Tagrisso) yielded clinical responses in patients who...
